Stockreport

Foundation Medicine Announces Partnership with Repare Therapeutics to Provide Genomic Profiling Services to Support Clinical Trials and to Develop Companion Diagnostic for Lunresertib [Yah...

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF leading clinical-stage precision oncology company, to provide prospective genomic profiling to patients in Repare's ongoing Phase I/Ib MYTHIC study ( NCT04855656 ) of lu [Read more]